Rafael Holdings, Inc. is a biotechnology company focused on developing pharmaceuticals and holding interests in clinical and early-stage companies. Its lead candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), in a Phase 3 trial for Niemann-Pick Disease Type C1 (NPC1). It also holds majority interests in LipoMedix (cancer therapy), Cornerstone Pharmaceuticals (cancer metabolism), Rafael Medical Devices (orthopedic minimally invasive surgery), and Day Three Labs (manufacturing technology), plus a curtailed cancer research entity, Barer Institute.
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-29 | 2025-07-31 | 0001213900-25-103549 | EDGAR | 120K words |
| 2024-11-07 | 2024-07-31 | 0001213900-24-095111 | EDGAR | 117K words |
| 2023-10-30 | 2023-07-31 | 0001213900-23-081589 | EDGAR | 97K words |
| 2022-10-31 | 2022-07-31 | 0001213900-22-067711 | EDGAR | — |
| 2021-10-18 | 2021-07-31 | 0001213900-21-053306 | EDGAR | — |
| 2020-10-29 | 2020-07-31 | 0001213900-20-033974 | EDGAR | — |
| 2019-10-04 | 2019-07-31 | 0001213900-19-019707 | EDGAR | — |
| 2018-10-15 | 2018-07-31 | 0001213900-18-013948 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2026-01-31 | 0001213900-26-028348 | EDGAR | 38K words |
| 2025-12-12 | 2025-10-31 | 0001213900-25-120897 | EDGAR | 32K words |
| 2025-06-11 | 2025-04-30 | 0001213900-25-053273 | EDGAR | 50K words |
| 2025-03-14 | 2025-01-31 | 0001213900-25-023799 | EDGAR | 48K words |
| 2024-12-11 | 2024-10-31 | 0001213900-24-107637 | EDGAR | 40K words |
| 2024-06-14 | 2024-04-30 | 0001213900-24-052918 | EDGAR | 46K words |
| 2024-03-14 | 2024-01-31 | 0001213900-24-022343 | EDGAR | 38K words |
| 2023-12-14 | 2023-10-31 | 0001213900-23-095748 | EDGAR | 31K words |
| 2023-06-13 | 2023-04-30 | 0001213900-23-048592 | EDGAR | — |
| 2023-03-14 | 2023-01-31 | 0001213900-23-019981 | EDGAR | — |
| 2022-12-13 | 2022-10-31 | 0001213900-22-079292 | EDGAR | — |
| 2022-06-14 | 2022-04-30 | 0001213900-22-032831 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-16 | 0001213900-26-028311 | EDGAR | 3K words |
| 2026-01-12 | 0001213900-26-003411 | EDGAR | 1K words |
| 2025-12-11 | 0001213900-25-120691 | EDGAR | 2K words |
| 2025-12-02 | 0001213900-25-116951 | EDGAR | 1K words |
| 2025-10-29 | 0001213900-25-103509 | EDGAR | 3K words |
| 2025-10-28 | 0001213900-25-103087 | EDGAR | 1K words |
| 2025-10-10 | 0001213900-25-097965 | EDGAR | 3K words |
| 2025-08-07 | 0001213900-25-073104 | EDGAR | 1K words |
| 2025-07-18 | 0001213900-25-065353 | EDGAR | 8K words |
| 2025-06-18 | 0001213900-25-055402 | EDGAR | 1K words |
167 total filings indexed. 137 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001713863 |
| Ticker | RFL |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Newark, New Jersey |
| Website | https://www.rafaelholdings.com |
| Listed | 2018-03-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RFL (~200 tokens, structured JSON with cryptographic provenance)